FundLens
38
Pharma & HealthcareAvoid

Tata India Pharma & Healthcare

Tata · Direct–Growth · rank #12 / 18 Smart Score ke hisaab se

Data updated

Tata India Pharma & Healthcare ka score 38/100 hai — 18 mein #12 Pharma & Healthcare fund (Avoid). Mazbooti: expense ratio (category mein 75th percentile). Kamzori: utaar-chadhaav (category mein 9th percentile).

Trailing returns

index ke muqable: Nifty 500 (index-fund proxy)
1 saal
9.1%
+10.1% index ke muqable
3 saal
22.0%
+10.4% index ke muqable
5 saal
14.8%
+3.1% index ke muqable
Launch se
13.7%

Saal-dar-saal performance

aakhri entry = is saal ab tak
2021
20.9%
2022
-6.6%
2023
38.6%
2024
42.5%
2025
-3.5%
2026
10.2%

Risk metrics

Sharpe ratio
1.05
↑ jitna zyada, utna accha
Sortino ratio
1.65
↑ jitna zyada, utna accha
Std deviation
17.16
↓ jitna kam, utna accha
Alpha
0.55
↑ jitna zyada, utna accha
Beta
0.97
≈1 yaani market ke saath

Isi category ke aur funds

Research aur education ke liye — investment advice nahi.